Zevra Therapeutics (ZVRA) Revenue Growth (1y) (2020 - 2026)
Zevra Therapeutics (ZVRA) Revenue Growth (1y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Revenue Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
37.90% |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
64.24% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
7.82% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Zevra Therapeutics |
787.90 Mn |
587.28 Mn |
34.30 Mn |
77.44% |
| Date | Value |
|---|
| Mar 31, 2026 |
77.44% |
| Dec 31, 2025 |
184.47% |
| Sep 30, 2025 |
605.36% |
| Jun 30, 2025 |
488.20% |
| Mar 31, 2025 |
500.03% |
| Dec 31, 2024 |
-7.03% |
| Sep 30, 2024 |
27.63% |
| Jun 30, 2024 |
-48.05% |
| Mar 31, 2024 |
7.05% |
| Dec 31, 2023 |
489.15% |
| Sep 30, 2023 |
0.73% |
| Jun 30, 2023 |
17,545.83% |
| Mar 31, 2023 |
-19.90% |
| Dec 31, 2022 |
-15.07% |
| Sep 30, 2022 |
46.26% |
| Jun 30, 2022 |
-99.60% |
| Mar 31, 2022 |
-67.28% |
| Dec 31, 2021 |
9.13% |
| Sep 30, 2021 |
2.08% |
| Jun 30, 2021 |
73.51% |
